Clinical Trial Update: Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dutasteride 0.5 mg for Chinese patients with benign prostatic hyperplasia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Dutasteride 0.5 mg (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia, Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2010-03-11